Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Skin
|
| gptkbp:approves |
gptkb:1994
gptkb:FDA |
| gptkbp:available_in |
various strengths
|
| gptkbp:available_on |
gptkb:pharmaceuticals
|
| gptkbp:brand |
Fluticasone nasal spray
|
| gptkbp:class |
gptkb:Android
|
| gptkbp:clinical_trial |
NCT00000123
NCT00000124 NCT00000125 NCT00000126 NCT00000127 |
| gptkbp:contraindication |
hypersensitivity to fluticasone
|
| gptkbp:dosage_form |
spray
|
| gptkbp:financial_support |
shake well before use
|
| gptkbp:formulation |
suspension
|
| https://www.w3.org/2000/01/rdf-schema#label |
Flonase
|
| gptkbp:indication |
seasonal allergies
perennial allergies |
| gptkbp:ingredients |
fluticasone propionate
|
| gptkbp:interacts_with |
antiviral medications
immunosuppressants antifungal medications live vaccines other nasal corticosteroids CYP3 A4 inhibitors |
| gptkbp:manufacturer |
gptkb:Glaxo_Smith_Kline
|
| gptkbp:mechanism_of_action |
anti-inflammatory
|
| gptkbp:packaging |
gptkb:bottle
|
| gptkbp:patient_population |
consult healthcare provider before use
do not exceed recommended dose do not use for more than 3 months without consulting a doctor may cause drowsiness in some patients may take several days to see full effect |
| gptkbp:requires |
no
|
| gptkbp:route_of_administration |
intranasal
|
| gptkbp:side_effect |
dizziness
fatigue headache nausea sleep disturbances cough sore throat vomiting nosebleeds throat irritation increased intraocular pressure nasal irritation dryness of the nasal mucosa adrenal suppression growth suppression in children |
| gptkbp:storage |
room temperature
|
| gptkbp:structure |
C22 H27 F3 O5 S
|
| gptkbp:used_for |
allergic rhinitis
|
| gptkbp:bfsParent |
gptkb:Vicks
|
| gptkbp:bfsLayer |
5
|